Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a 14.198\% hERG inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
(a) Cc1ccc(N2C(=O)c3ccc(C(=O)N4CCN(c5ccc(C)c(C)c5)CC4)cc3C2=O)cc1
(b) COc1ccc(CC2C(=O)N(c3ccccc3)C(=O)N(c3ccccc3)C2=O)c(OC)c1
(c) COc1ccc([C@@H]2CC(=O)c3c(O)cc(O[C@@H]4OC(CO[C@@H]5OC(C)[C@H](O)[C@H](O)C5O)[C@@H](O)[C@@H](O)C4O)cc3O2)cc1O
(d) CCC(=O)c1cn2c(c1CC)CCC[C@H]2CCO
Answer: d. CCC(=O)c1cn2c(c1CC)CCC[C@H]2CCO
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(=O)c1cn2c(c1CC)CCC[C@H]2CCO
CCC(=O)c1cn2c(c1CC)CCC[C@H]2CCO
1-[(5S)-1-ethyl-5-(2-hydroxyethyl)-5,6,7,8-tetrahydroindolizin-2-yl]propan-1-one